Search results
Yutaka UEDA | Cited by 4,586 | of Osaka University, Osaka (Handai) | Read 304 publications | Contact Yutaka UEDA
Jul 1, 2021 · Yutaka Ueda received a grant (15ck0106103h0102) from the Japan Agency for Medical Research and Development, and lecture fees from Merck Sharp & Dohme. T. Kimura received research funds from Merck Sharp & Dohme.
Dec 21, 2018 · Summary: Researchers at Osaka University present measures for reducing a risk of uterine cervical cancer that increased by the suspension of the Japanese government recommendation for the Human Papillomavirus (HPV) vaccination and for promoting HPV vaccination after its resumption.
If Japan’s government reinstates a proactive recommendation of the HPV vaccine, Japan will become a health-conscious country. We are now willing and able to provide serious medical treatment to any vaccinated or unvaccinated woman who presents with the purported adverse symptoms.
- Sayaka Ikeda, Yutaka Ueda, Asami Yagi, Shinya Matsuzaki, Eiji Kobayashi, Tadashi Kimura, Etsuko Miya...
- 2019
Sep 29, 2020 · Ueda, Y. et al. Japan’s failure to vaccinate females against human papillomavirus. Am J Obstet Gynecol 212, 405–406 (2015). Article Google Scholar
- Asami Yagi, Yutaka Ueda, Satoshi Nakagawa, Sayaka Ikeda, Yusuke Tanaka, Masayuki Sekine, Etsuko Miya...
- 2020
Sep 30, 2020 · Open access. Published: 30 September 2020. The last strategy for re-dissemination of HPV vaccination in Japan while still under the suspension of the governmental recommendation. Yutaka Ueda,...
Oct 6, 2017 · Yutaka Ueda received a grant from the Japan Agency for Medical Research and Development (Grant Number 15ck0106103h0102) and has received lecture fees from GlaxoSmithKline/Japan Vaccine and received lecture fees, research funds, and consultation fees from Merck Sharp & Dohme.
